Home Featured

Featured

Random

Filament Health Announces Pre-ind Meeting With United States Food And Drug Administration

Silo Pharma (SILO) Announces Plans to Uplist to the NASDAQ

Entheon Biomedical Announces DMT Drug Supply Agreement with Ofichem Group

Pα+ Psychedelic Bulletin #215: FDA’s Move to Single-Trial Approvals; Freedom to Heal Act Looks to Unlock Right to Try Psychedelics; Compass Clarifies Q1 Readout...

Beckley Psytech Strengthens Pipeline and Development Team With Acquisition of Eleusis Therapeutics Limited

Developing Cultural Awareness in Business & Practice

Psyched Wellness Announces Matthew Singh Joins Team as CPG and Branding...

BetterLife Obtains Favourable Animal Safety Data for Repeated Oral Dosing of...

Psychedelic vs. Hallucinogen-What’s in a Name?

PT448 – Ibogaine, Noribogaine, and the Challenges of Federal Drug Policy

Mind Cure Announces Addition of Global Technology Leader Robert C. Hill...

Psychedelic Health – New course launches to bridge the psychedelic education...

Numinus Wellness To Acquire Neurology Centre of Toronto, Plans to Create...

MindMed Closes Acquisition of HealthMode, a Leading Machine Learning Digital Medicine...

MYDECINE INNOVATIONS GROUP FILES PROSPECTUS SUPPLEMENT AND ANNOUNCES CLOSING UNDER SHARE...

12 3...312 Page 1 of 312

EDITOR PICKS

The Psychedelic Writers Guild’s Denver Mixer

The Mushroom Cure – Special Live Filming

Pα+ Psychedelic Bulletin #222: Unpacking EPIsoDE; Meta-Analysis Says Psychedelics No Better...

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.